Fig. 8From: The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease modelthe expression of VEGF in the kidney tissue, a control, b CK model, c treated with CWJMSCs. d The area percent of VEGF expression in immunohistochemically stained sections in all experimental groups. Columns bearing different lowercase letters are considered significant at P value < 0.05Back to article page